⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RANI News
Rani Therapeutics Holdings, Inc. Class A Common Stock
Osteoporosis Market Set to Expand Significantly During the Forecast Period (2025-2034) Due to Rising Aging Population and Novel Therapeutics | DelveInsight
prnewswire.com
AMGN
UCB
ENTX
RANI
ANGI
Rani Therapeutics Reports Third Quarter 2025 Financial Results; Provides Corporate Update
globenewswire.com
RANI
Rani Therapeutics to Present Preclinical Data on Oral Delivery of Semaglutide via the RaniPill® Capsule at ObesityWeek® 2025
globenewswire.com
RANI
Rani Therapeutics Announces the Appointments of Abe Bassan and Vasudev Bailey, Ph.D. to Board of Directors
globenewswire.com
RANI
Rani Therapeutics Announces Closing of Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
globenewswire.com
RANI
Rani Therapeutics Announces up to $1.085 Billion Collaboration with Chugai Pharmaceutical Co. for Multiple High-Value Therapeutics Including Rare Disease and Immunology Programs and Announces Concurrent Oversubscribed $60.3 Million Financing
globenewswire.com
RANI
Rani Therapeutics Announces Oversubscribed $60.3 Million Private Placement Priced At-the-Market under Nasdaq Rules
globenewswire.com
RANI